Sex-specific differences in CYP450 isoforms in humans

Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians

Shimada, T., Yamazaki, H., Mimura, M., Inui, Y., & Guengerich, F. P. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22379-5 · Cited by 2,785 · see citing works

CYTOCHROME P-450 3A4: Regulation and Role in Drug Metabolism

Guengerich, F. P. (1999) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.39.1.1 · Cited by 1,271 · see citing works

The major genetic defect responsible for the polymorphism of S-mephenytoin metabolism in humans.

de Morais, S. M., Wilkinson, G. R., Blaisdell, J. A., Nakamura, K., Meyer, U., & Goldstein, J. A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)40694-6 · Cited by 956 · see citing works

Clinical Significance of the Cytochrome P450 2C19 Genetic Polymorphism

Desta, Z., Zhao, X., Shin, J.-G., & Flockhart, D. A. (2002) · Clinical Pharmacokinetics · doi:10.2165/00003088-200241120-00002 · Cited by 942 · see citing works

Cytochromes P450 and metabolism of xenobiotics

Anzenbacher, P., & Anzenbacherová, E. (2001) · Cellular and Molecular Life Sciences · doi:10.1007/pl00000897 · Cited by 890 · see citing works

Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P‐glycoprotein: Implications for drug delivery and activity in cancer chemotherapy

Wacher, V. J., Wu, C., & Benet, L. Z. (1995) · Molecular Carcinogenesis · doi:10.1002/mc.2940130302 · Cited by 862 · see citing works

Cytochrome P450 2D6: overview and update on pharmacology, genetics, biochemistry

Zanger, U. M., Raimundo, S., & Eichelbaum, M. F. (2004) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-003-0832-2 · Cited by 806 · see citing works

Identification of a new genetic defect responsible for the polymorphism of (S)-mephenytoin metabolism in Japanese.

Morais, S. M. D., Wilkinson, G. R., Blaisdell, J. A., Meyer, U., Nakamura, K., & Goldstein, J. A. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09788-3 · Cited by 752 · see citing works

Functional significance of a C–>A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine

Sachse, C., Brockmöller, J., Bauer, S., & Roots, I. (1999) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1999.00898.x · Cited by 751 · see citing works

Pregnancy-Induced Changes in Pharmacokinetics

Anderson, G. D. (2005) · Clinical Pharmacokinetics · doi:10.2165/00003088-200544100-00001 · Cited by 650 · see citing works

Oral first-pass elimination of midazolam involves both gastrointestinal and hepatic CYP3A-mediated metabolism*

Thummel, K. E., O’Shea, D., Paine, M. F., Shen, D. D., Kunze, K. L., Perkins, J. D., & Wilkinson, G. R. (1996) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(96)90177-0 · Cited by 615 · see citing works

Effect of Age, Gender, and Obesity on Midazolam Kinetics

Greenblatt, D. J., Abernethy, D. R., Locniskar, A., Harmatz, J. S., Limjuco, R. A., & Shader, R. I. (1984) · Anesthesiology · doi:10.1097/00000542-198407000-00006 · Cited by 580 · see citing works

Oxidative and reductive metabolism by cytochrome P450 2E1

Koop, D. R. (1992) · The FASEB Journal · doi:10.1096/fasebj.6.2.1537462 · Cited by 561 · see citing works

Sex Differences in Pharmacokinetics and Pharmacodynamics

Gandhi, M., Aweeka, F. T., Greenblatt, R. M., & Blaschke, T. F. (2004) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.44.101802.121453 · Cited by 546 · see citing works

Identification of glucocorticoid-inducible cytochromes P-450 in the intestinal mucosa of rats and man.

Watkins, P. B., Wrighton, S. A., Schuetz, E. G., Molowa, D. T., & Guzelian, P. S. (1987) · Journal of Clinical Investigation · doi:10.1172/jci113156 · Cited by 480 · see citing works

Clinical consequences of cytochrome P450 2C9 polymorphisms

Kirchheiner, J., & Brockmöller, J. (2005) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2004.08.009 · Cited by 473 · see citing works

Effect of Age, Gender, and Obesity on Midazolam Kinetics

Greenblatt, D. J., Abernethy, D. R., Locniskar, A., et al. (1984) · Anesthesiology · doi:10.1097/00000542-198461010-00006 · Cited by 461 · see citing works

Accelerated Metabolism of Nicotine and Cotinine in Pregnant Smokers

Dempsey, D., Jacob, P., & Benowitz, N. L. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.301.2.594 · Cited by 452 · see citing works

Effect of age and gender on the activity of human hepatic CYP3A

Hunt, C. M., Westerkam, W. R., & Stave, G. M. (1992) · Biochemical Pharmacology · doi:10.1016/0006-2952(92)90010-g · Cited by 426 · see citing works

The contribution of intestinal and hepatic CYP3A to the interaction between midazolam and clarithromycin*

Gorski, J. C., Jones, D. R., HAEHNERDANIELS, B., Hamman, M. A., O'Mara, E. M., & Hall, S. D. (1998) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(98)90146-1 · Cited by 409 · see citing works

Pharmacogenetics, Drug-Metabolizing Enzymes, and Clinical Practice

Gardiner, S. J., & Begg, E. J. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.6 · Cited by 406 · see citing works

Pronounced differences between native Chinese and Swedish populations in the polymorphic hydroxylations of debrisoquin and S-mephenytoin

Bertilsson, L., Lou, Y., Du, Y.-L., Liu, Y., Kuang, T.-Y., Liao, X.-M., Wang, K., Reviriego, J., Iselius, L., & Sjöqvist, F. (1992) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1992.38 · Cited by 399 · see citing works

Gastrointestinal transit: The effect of the menstrual cycle

Wald, A., Van Thiel, D. H., Hoechstetter, L., Gavaler, J. S., Egler, K. M., Verm, R., Scott, L., & Lester, R. (1981) · Gastroenterology · doi:10.1016/0016-5085(81)90263-8 · Cited by 397 · see citing works

CYP2C9 Genotype-guided Warfarin Prescribing Enhances the Efficacy and Safety of Anticoagulation: A Prospective Randomized Controlled Study

Caraco, Y., Blotnick, S., & Muszkat, M. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100316 · Cited by 358 · see citing works

Frequencies of the defective CYP2C19 alleles responsible for the mephenytoin poor metabolizer phenotype in various Oriental, Caucasian, Saudi Arabian and American black populations

Goldstein, J. A., Ishizaki, T., Chiba, K., de Morais, S. M. F., Bell, D. A., Krahn, P. M., & Evans, D. A. P. (1997) · Pharmacogenetics · doi:10.1097/00008571-199702000-00008 · Cited by 350 · see citing works

Genetic Polymorphism in the 5'-Flanking Region of HumanCYP1A2 Gene: Effect on the CYP1A2 Inducibility in Humans

Nakajima, M., Yokoi, T., Mizutani, M., Kinoshitah, M., Funayama, M., & Kamataki, T. (1999) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a022352 · Cited by 345 · see citing works

Influence of CYP2C9 and CYP2C19 genetic polymorphisms on warfarin maintenance dose and metabolic clearance

Scordo, M. G. (2002) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2002.129321 · Cited by 344 · see citing works

Variability of gastrointestinal transit in healthy women and men.

Degen, L. P., & Phillips, S. F. (1996) · Gut · doi:10.1136/gut.39.2.299 · Cited by 339 · see citing works

Racial and gender differences in N-acetyltransferase, xanthine oxidase, and CYP1A2* activities

Relling, M. V., Lin, J., Ayers, G. D., & Evans, W. E. (1992) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1992.203 · Cited by 314 · see citing works

Influence of gender and menopause on gastric emptying and motility

Hutson, W. R., Roehrkasse, R. L., & Wald, A. M. (1989) · Gastroenterology · doi:10.1016/0016-5085(89)90758-0 · Cited by 304 · see citing works

Genetic polymorphism of S-mephenytoin hydroxylation

Wilkinson, G. R., Guengerich, F. P., & Branch, R. A. (1989) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(89)90047-8 · Cited by 292 · see citing works

The Influence of Age and Sex on the Clearance of Cytochrome P450 3A Substrates

Cotreau, M. M., Moltke, L. L., & Greenblatt, D. J. (2005) · Clinical Pharmacokinetics · doi:10.2165/00003088-200544010-00002 · Cited by 291 · see citing works

Gender-related differences in gastric emptying.

Datz, F. L., Christian, P. E., & Moore, J. G. (1987) · PubMed · Cited by 281 · see citing works

Interindividual variation in expression of P-glycoprotein in normal human liver and secondary hepatic neoplasms.

Schuetz, E. G., Furuya, K. N., & Schuetz, J. D. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12089-2 · Cited by 266 · see citing works

Sensitivity to triazolam in the elderly

Greenblatt, D. J., Harmatz, J. S., Shapiro, L., Engelhardt, N., Gouthro, T. A., & Shader, R. I. (1991) · New England Journal of Medicine · doi:10.1056/nejm199106133242403 · Cited by 258 · see citing works

Differentiation of intestinal and hepatic cytochrome P450 3A activity with use of midazolam as an in vivo probe: Effect of ketoconazole

Tsunoda, S. M., VELEZ, R., VONMOLTKE, L., & Greenblatt, D. J. (1999) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(99)70009-3 · Cited by 257 · see citing works

Drug-Metabolizing Enzymes Mechanisms and Functions

Sheweita, S. A. (2000) · Current Drug Metabolism · doi:10.2174/1389200003339117 · Cited by 246 · see citing works

Induction of CYP2D6 in pregnancy*

Wadelius, M., Darj, E., Frenne, G., & Rane, A. (1997) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(97)90118-1 · Cited by 226 · see citing works

Cloning and expression of complementary DNAs for multiple members of the human cytochrome P450IIC subfamily

Romkes, M., Faletto, M. B., Blaisdell, J. A., Raucy, J. L., & Goldstein, J. A. (1991) · Biochemistry · doi:10.1021/bi00227a012 · Cited by 209 · see citing works

Pharmacogenetics of cytochrome P4502D6: genetic background and clinical implication

Cascorbi, I. (2003) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.33.s2.3.x · Cited by 206 · see citing works

Cytochrome P450 2E1: its clinical and toxicological role

Tanaka, Terada, & Misawa (2000) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1046/j.1365-2710.2000.00282.x · Cited by 203 · see citing works

Effects of age and gender on in vitro properties of human liver microsomal monooxygenases

Schmucker, D. L., Woodhouse, K. W., Wang, R. K., Wynne, H., James, O., McManus, M. E., & Kremers, P. G. (1990) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1990.164 · Cited by 202 · see citing works

A New Genetic Defect in Human CYP2C19: Mutation of the Initiation Codon Is Responsible for Poor Metabolism of S-Mephenytoin

Ferguson, R. J., de Morais, S. M. F., Benhamou, S., et al. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37213-1 · Cited by 200 · see citing works

The influence of environmental and genetic factors on CYP2D6, CYP1A2 and UDP-glucuronosyltransferases in man using sparteine, caffeine, and paracetamol as probes

Bock, K. W., Schrenk, D., Forster, A., Griese, E., rike, K. M., Brockmeier, D., & Eichelbaum, M. F. (1994) · Pharmacogenetics · doi:10.1097/00008571-199408000-00005 · Cited by 199 · see citing works

Pharmacogenetics and psychopharmacotherapy

Poolsup, Po, A. L. W., & Knight (2000) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1046/j.1365-2710.2000.00281.x · Cited by 197 · see citing works

Genetic Polymorphism of CYP1A2 in Ethiopians Affecting Induction and Expression: Characterization of Novel Haplotypes with Single-Nucleotide Polymorphisms in Intron 1

Aklillu, E., Carrillo, J. A., Makonnen, E., Hellman, K., Pitarque, M., Bertilsson, L., & Ingelman‐Sundberg, M. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.3.659 · Cited by 181 · see citing works

Differences in the Incidence of the CYP2C19 Polymorphism Affecting the S-Mephenytoin Phenotype in Chinese Han and Bai Populations and Identification of a New Rare CYP2C19 Mutant Allele

Xiao, Z., Goldstein, J. A., Xie, H., Blaisdell, J. A., Wang, W., Jiang, C.-H., Yan, F., He, N., Huang, S.-L., Xu, Z., et al. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36606-6 · Cited by 174 · see citing works

Physiological Changes During the Menstrual Cycle and Their Effects on the Pharmacokinetics and Pharmacodynamics of Drugs

Kashuba, A. D. M., & Nafziger, A. N. (1998) · Clinical Pharmacokinetics · doi:10.2165/00003088-199834030-00003 · Cited by 167 · see citing works

Sex‐related differences in the clearance of cytochrome P450 3A4 substrates may be caused by P‐glycoprotein

Cummins, C. L., Wu, C., & Benet, L. Z. (2002) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2002.128388 · Cited by 167 · see citing works

Influence of gender and oral contraceptives on CYP2D6 and CYP2C19 activity in healthy volunteers

Hägg, S., Spigset, O., & Dahlqvist, R. (2001) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2001.01328.x · Cited by 164 · see citing works

Effects of Gender and Age on Plasma Levels of Clozapine and Its Metabolites

Lane, H., Chang, Y.-C., Chang, W., Lin, S., Tseng, Y.-T., & Jann, M. W. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0108 · Cited by 158 · see citing works

Interindividual variability of chlorzoxazone 6-hydroxylation in men and women and its relationship to CYP2E1 genetic polymorphisms*

Kim, R. B., O’Shea, D., & Wilkinson, G. R. (1995) · Clinical Pharmacology & Therapeutics · doi:10.1016/0009-9236(95)90227-9 · Cited by 155 · see citing works

Bioequivalence revisited: Influence of age and sex on CYP enzymes

Bebia, Z., Buch, S. C., WILSON, J., Frye, R. F., Romkes-Sparks, M., Cecchetti, A. A., Chaves‐Gnecco, D., & BRANCH, R. (2004) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2004.08.021 · Cited by 152 · see citing works

Effects of obesity on the cytochrome P450 enzyme system.

Kotlyar, M., & Carson, S. W. (1999) · PubMed · Cited by 152 · see citing works

Age but not gender selectively affects expression of individual cytochrome P450 proteins in human liver

George, J., Byth, K., & Farrell, G. C. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00192-3 · Cited by 146 · see citing works

Oxidative metabolism of omeprazole in human liver microsomes: cosegregation with S-mephenytoin 4'-hydroxylation.

Chiba, K., Kobayashi, K., Manabe, K., et al. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38328-x · Cited by 145 · see citing works

CYP2D6 and CYP2C19 activity in a large population of Dutch healthy volunteers: indications for oral contraceptive-related gender differences

Tamminga, W. J., Wemer, J., Oosterhuis, B., Wieling, J., Wilffert, B., de Leij, L. F. M. H., de Zeeuw, R. A., & Jonkman, J. H. G. (1999) · European Journal of Clinical Pharmacology · doi:10.1007/s002280050615 · Cited by 144 · see citing works

Imipramine and desipramine disposition in the elderly.

Abernethy, D. R., Greenblatt, D. J., & Shader, R. I. (1985) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20086-6 · Cited by 143 · see citing works

The mephenytoin oxidation polymorphism is partially responsible for the N-demethylation of imipramine

Skjelbo, E., Brøsen, K., Hallas, J., et al. (1991) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1991.4 · Cited by 141 · see citing works

Comparison of urinary 6-β-cortisol and the erythromycin breath test as measures of hepatic P450IIIA (CYP3A) activity

Watkins, P. B., Turgeon, D. K., Saenger, P. H., et al. (1992) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1992.140 · Cited by 139 · see citing works

Serum protein binding of drugs during and after pregnancy in humans

Dean, M. E., Stock, B. H., Patterson, R. J., & Levy, G. (1980) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1980.158 · Cited by 139 · see citing works

The pharmacokinetics of atovaquone and proguanil in pregnant women with acute falciparum malaria

McGready, R., Stepniewska, K., Edstein, M. D., Cho, T., Gilveray, G., Looareesuwan, S., White, N. J., & Nosten, F. (2003) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-003-0652-9 · Cited by 138 · see citing works

Genetic analysis of the S-mephenytoin polymorphism in a chinese population*

de Morais, S. M. F., Goldstein, J. A., Xie, H., et al. (1995) · Clinical Pharmacology & Therapeutics · doi:10.1016/0009-9236(95)90053-5 · Cited by 134 · see citing works

Phenotypic polymorphism and gender‐related differences of CYP1A2 activity in a Chinese population

Ou‐Yang, D., Huang, S., Wang, W., Xie, H., Xu, Z., Shu, Y., & Zhou, H. (2000) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2000.00128.x · Cited by 133 · see citing works

The Pharmocogenomics of Warfarin: Closing in on Personalized Medicine

Rettie, A. E. (2006) · Molecular Interventions · doi:10.1124/mi.6.4.8 · Cited by 132 · see citing works

Gender-Based Differences in Pharmacokinetics in Laboratory Animal Models

Czerniak, R. (2001) · International Journal of Toxicology · doi:10.1080/109158101317097746 · Cited by 132 · see citing works

The erythromycin breath test predicts the clearance of midazolam*

Lown, K. S., Thummel, K. E., Benedict, P. E., Shen, D. D., Turgeon, D. K., Berent, S., & Watkins, P. B. (1995) · Clinical Pharmacology & Therapeutics · doi:10.1016/0009-9236(95)90261-9 · Cited by 131 · see citing works

Identification of New Human CYP2C19 Alleles (CYP2C19*6 and CYP2C19*2B) in a Caucasian Poor Metabolizer of Mephenytoin

Ibeanu, G. C., Goldstein, J. A., Meyer, U., Benhamou, S., Bouchardy, C., Dayer, P., Ghanayem, B. I., & Blaisdell, J. A. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37748-1 · Cited by 127 · see citing works

Prednisolone Pharmacokinetics and Pharmacodynamics in Relation to Sex and Race

Magee, M. H., Blum, R. A., Lates, C. D., & Jusko, W. J. (2001) · The Journal of Clinical Pharmacology · doi:10.1177/00912700122012733 · Cited by 125 · see citing works

The effect of pregnancy on cytochrome P4501A2, xanthine oxidase, and N -acetyltransferase activities in humans

Tsutsumi, K. (2001) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2001.116495 · Cited by 124 · see citing works

Comparative Kinetics and Response to the Benzodiazepine Agonists Triazolam and Zolpidem: Evaluation of Sex-Dependent Differences

Greenblatt, D. J., Harmatz, J. S., Moltke, L. L., Wright, C. E., Durol, A. L. B., Harrel-Joseph, L. M., & Shader, R. I. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39253-5 · Cited by 123 · see citing works

Inhibition of Caffeine Metabolism by Estrogen Replacement Therapy in Postmenopausal Women

Pollock, B. G., Wylie, M. E., STACK, J. A., Sorisio, D. A., Thompson, D. S., Kirshner, M. A., Folan, M., & Condifer, K. A. (1999) · The Journal of Clinical Pharmacology · doi:10.1177/00912709922008560 · Cited by 120 · see citing works

Incidence of S-mephenytoin hydroxylation deficiency in a Korean population and the interphenotypic differences in diazepam pharmacokinetics

Sohn, D., Kusaka, M., Ishizaki, T., et al. (1992) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1992.125 · Cited by 119 · see citing works

Gender‐Specific Effects on Verapamil Pharmacokinetics and Pharmacodynamics in Humans

KRECICSHEPARD, M., Barnas, C., SLIMKO, J., Jones, M. P., & Schwartz, J. B. (2000) · The Journal of Clinical Pharmacology · doi:10.1177/00912700022008883 · Cited by 116 · see citing works

Diazepam Kinetics in Relation to Age and Sex

Ochs, H. R., Greenblatt, D. J., Divoll, M., Abernethy, D. R., Feyerabend, H., & Dengler, H. J. (2008) · Pharmacology · doi:10.1159/000137524 · Cited by 114 · see citing works

Intersubject and dose‐related variability after intravenous administration of erythromycin.

Austin, K., Mather, L. E., Philpot, C. R., et al. (1980) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1980.tb01755.x · Cited by 112 · see citing works

No sex-related differences but significant inhibition by oral contraceptives of CYP2C19 activity as measured by the probe drugs mephenytoin and omeprazole in healthy Swedish white subjects

Laine, K. (2000) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2000.108949 · Cited by 109 · see citing works

Cytochrome P450 mediated metabolism of diazepam in human and rat: involvement of human CYP2C in N-demethylation in the substrate concentration-dependent manner

Yasumori, T., Nagata, K., Yang, S. K., et al. (1993) · Pharmacogenetics · doi:10.1097/00008571-199312000-00003 · Cited by 108 · see citing works

DO MEN AND WOMEN DIFFER IN PROXIMAL SMALL INTESTINAL CYP3A OR P-GLYCOPROTEIN EXPRESSION?

Paine, M. F., Ludington, S. S., Chen, M.-L., Stewart, P. W., Huang, S.-M., & Watkins, P. B. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.002469 · Cited by 108 · see citing works

A Novel Transversion in the Intron 5 Donor Splice Junction of CYP2C19 and a Sequence Polymorphism in Exon 3 Contribute to the Poor Metabolizer Phenotype for the Anticonvulsant Drug S-Mephenytoin

Ibeanu, G. C., Blaisdell, J. A., Ferguson, R. J., Ghanayem, B. I., Brøsen, K., Benhamou, S., Bouchardy, C., Wilkinson, G. R., Dayer, P., & Goldstein, J. A. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)34944-4 · Cited by 108 · see citing works

Quantification of 3-month intraindividual variability and the influence of sex and menstrual cycle phase on CYP3A activity as measured by phenotyping with intravenous midazolam*

Kashuba, A. D. M., Bertino, J., Rocci, M. L., et al. (1998) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(98)90175-8 · Cited by 107 · see citing works

Alprazolam Kinetics in the Elderly

Greenblatt, D. J. (1983) · Archives of General Psychiatry · doi:10.1001/archpsyc.1983.01790030057007 · Cited by 105 · see citing works

Race and sex influence clearance of nifedipine: Results of a population study

KRECICSHEPARD, M. (2000) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2000.108678 · Cited by 104 · see citing works

Pharmacokinetics during pregnancy: evidence-based maternal dose formulation

Little, B. B. (1999) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(98)00444-x · Cited by 102 · see citing works

Association of aromatase (CYP 19) gene variation with features of hyperandrogenism in two populations of young women

Petry, C. J., Ong, K. K., Michelmore, K. F., Artigas, S., Wingate, D. L., Balen, A. H., de Zegher, F., Ibáñez, L., & Dunger, D. B. (2005) · Human Reproduction · doi:10.1093/humrep/deh900 · Cited by 99 · see citing works

An additional defective allele, CYP2C19*5, contributes to the S-mephenytoin poor metabolizer phenotype in Caucasians

Ibeanu, G. C., Blaisdell, J. A., Ghanayem, B. I., et al. (1998) · Pharmacogenetics · doi:10.1097/00008571-199804000-00006 · Cited by 98 · see citing works

Age and gender effects on the pharmacokinetics and pharmacodynamics of triazolam, a cytochrome P450 3A substrate

GREENBLATT, D., HARMATZ, J., VONMOLTKE, L., WRIGHT, C., & SHADER, R. (2004) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2004.07.009 · Cited by 93 · see citing works

Reduced clearance of triazolam in old age: relation to antipyrine oxidizing capacity.

Greenblatt, D. J., Divoll, M., Abernethy, D., Moschitto, L. J., Smith, R. B., & Shader, R. I. (1983) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1983.tb01503.x · Cited by 92 · see citing works

Influence of age and gender on risperidone plasma concentrations

Aichhorn, W., Weiss, U., Marksteiner, J., et al. (2005) · Journal of Psychopharmacology · doi:10.1177/0269881105053306 · Cited by 89 · see citing works

Frequency distribution of dapsone N-hydroxylase, a putative probe for P4503A4 activity, in a white population

May, D. G., Porter, J., Wilkinson, G. R., et al. (1994) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1994.62 · Cited by 89 · see citing works

Gender difference in ifosfamide metabolism by human liver microsomes

Schmidt, R., Baumann, F., Hanschmann, H., Geißler, F., & Preiß, R. (2001) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/bf03190396 · Cited by 88 · see citing works

Inhibition of cytochrome P450 2B6 activity by hormone replacement therapy and oral contraceptive as measured by bupropion hydroxylation

Palovaara, S. (2003) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(03)00202-9 · Cited by 87 · see citing works

Age and gender effects on ondansetron pharmacokinetics: Evaluation of healthy aged volunteers

Pritchard, J. F., Bryson, J. C., Kernodle, A. E., et al. (1992) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1992.7 · Cited by 85 · see citing works

Effects of Age, Gender and Oral Contraceptives on Intramuscular Midazolam Pharmacokinetics

Holazo, A. A., Winkler, M. B., & Patel, I. H. (1988) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1988.tb03127.x · Cited by 85 · see citing works

Gender, age, smoking behaviour and plasma clozapine concentrations in 193 Chinese inpatients with schizophrenia

Tang, Y., Mao, P., Li, F., Li, W., Chen, Q., Jiang, F., Cai, Z., & Mitchell, P. B. (2007) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2007.02852.x · Cited by 78 · see citing works

The distribution and gender difference of CYP3A activity in Chinese subjects

Zhu, B. Y., Liu, Z., Chen, G., et al. (2003) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2003.01728.x · Cited by 78 · see citing works

Clomipramine Metabolism

Gex‐Fabry, M., Balant-Gorgia, A. E., Balant, L. P., & Garrone, G. (1990) · Clinical Pharmacokinetics · doi:10.2165/00003088-199019030-00007 · Cited by 75 · see citing works

Faster clearance of sustained release verapamil in men versus women: Continuing observations on sex-specific differences after oral administration of verapamil

KRECICSHEPARD, M. (2000) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2000.109356 · Cited by 74 · see citing works

Phenotyping polymorphic drug metabolism in the French Caucasian population

Jacqz, E., Dulac, H., & Mathieu, H. (1988) · European Journal of Clinical Pharmacology · doi:10.1007/bf00609247 · Cited by 74 · see citing works

Effect of age, height, weight and sex on serum phenytoin concentration in epileptic patients.

Houghton, G. W., Richens, A., & Leighton, M. (1975) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1975.tb01583.x · Cited by 72 · see citing works

Effect of Subject Age and Gender on the Pharmacokinetics of Oral Triazolam and Temazepam

Smith, R. B., Divoll, M., Gillespie, W. R., & Greenblatt, D. J. (1983) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-198306000-00005 · Cited by 71 · see citing works

Sex differences in CYP3A activity using intravenous and oral midazolam

CHEN, M., MA, L., Drusano, G. L., BERTINOJR, J., & Nafziger, A. N. (2006) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2006.08.014 · Cited by 68 · see citing works

Influence of ethinylestradiol-containing combination oral contraceptives with gestodene or levonorgestrel on caffeine elimination

Balogh, A., Henschel, L., Klinger, G., Vollanth, R., B�rner, A., & Kuhnz, W. (1995) · European Journal of Clinical Pharmacology · doi:10.1007/bf00192743 · Cited by 66 · see citing works

Thiothixene Pharmacokinetic Interactions

Ereshefsky, L., Saklad, S. R., Watanabe, M. D., et al. (1991) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199110000-00004 · Cited by 65 · see citing works

The effects of menopause and hormone replacement therapies on prednisolone and erythromycin pharmacokinetics*

Harris, R. Z., Tsunoda, S. M., Mroczkowski, P. J., Wong, H., & Benet, L. Z. (1996) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(96)90112-5 · Cited by 64 · see citing works

Population pharmacokinetics of riluzole in patients with amyotrophic lateral sclerosis

Bruno, R., Vivier, N., Montay, G., et al. (1997) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(97)90047-3 · Cited by 64 · see citing works

The G−113A polymorphism in affects the caffeine metabolic ratio in a Chinese population

Chen, X., WANG, L., ZHI, L., Zhou, G.-D., WANG, H., ZHANG, X., Hao, B., Zhu, Y., Cheng, Z., & HE, F. (2005) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2005.05.012 · Cited by 63 · see citing works

Influence of menstrual cycle and gender on alprazolam pharmacokinetics

Kirkwood, C. K., Moore, A. S., Hayes, P. E., DeVane, C. L., & Pelonero, A. L. (1991) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1991.157 · Cited by 62 · see citing works

Gaps in knowledge in treating pregnant women

Mattison, D. R., & Zajicek, A. (2006) · Gender Medicine · doi:10.1016/s1550-8579(06)80205-6 · Cited by 61 · see citing works

Lack of Gender Differences and Large Intrasubject Variability in Cytochrome P450 Activity Measured by Phenotyping with Dextromethorphan

McCune, J. S., Lindley, C. M., Decker, J. L., et al. (2001) · The Journal of Clinical Pharmacology · doi:10.1177/00912700122010627 · Cited by 61 · see citing works

Lidocaine disposition—Sex differences and effects of cimetidine

Wing, L. M. H., Miners, J. O., Birkett, D. J., Foenander, T., Lillywhite, K. J., & Wanwimolruk, S. (1984) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1984.97 · Cited by 59 · see citing works

Meta-analysis of phenotype and genotype of NAT2 deficiency in Chinese populations

Xie, H., Xu, Z., Ouyang, D., et al. (1997) · Pharmacogenetics · doi:10.1097/00008571-199712000-00009 · Cited by 59 · see citing works

Distinguishing a benzodiazepine agonist (triazolam) from a nonagonist anxiolytic (buspirone) by electroencephalography: Kinetic-dynamic studies

Greenblatt, D. J., Harmatz, J. S., Gouthro, T. A., Locke, J., & Shader, R. I. (1994) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1994.106 · Cited by 59 · see citing works

Cigarette Smoking, Metabolic Activation and Carcinogenesis

Nishikawa, A., Mori, Y., Lee, I., et al. (2004) · Current Drug Metabolism · doi:10.2174/1389200043335441 · Cited by 58 · see citing works

Chloroguanide metabolism in relation to the efficacy in malaria prophylaxis and the S-mephenytoin oxidation in Tanzanians*

Skjelbo, E., Mutabingwa, T. K., Bygbjerg, I. C., et al. (1996) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(96)80008-7 · Cited by 54 · see citing works

Population analyses of sustained‐release verapamil in patients: Effects of sex, race, and smoking

Kang, D., Verotta, D., KRECICSHEPARD, M., Modi, N. B., Gupta, S., & Schwartz, J. B. (2003) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2003.21 · Cited by 54 · see citing works

Bromazepam pharmacokinetics: Influence of age, gender, oral contraceptives, cimetidine, and propranolol

Ochs, H. R., Greenblatt, D. J., Friedman, H. L., et al. (1987) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1987.72 · Cited by 53 · see citing works

Variation in Response to Anticonvulsants in a Group of Epileptic Patients

Travers, R. D., Reynolds, E. H., & Gallagher, B. B. (1972) · Archives of Neurology · doi:10.1001/archneur.1972.00490130031004 · Cited by 49 · see citing works

The effect of gender on the pharmacokinetics of verapamil and norverapamil in human

Dadashzadeh, S., Javadian, B., & Sadeghian, S. (2006) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.512 · Cited by 49 · see citing works

Pharmacokinetic Studies in Pregnant Women

Anger, G. J., & Piquette‐Miller, M. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100377 · Cited by 48 · see citing works

Effects of Age, Sex, Obesity, and Pregnancy on Plasma Diphenylhydantoin Levels

Sherwin, A. L., Loynd, J. S., Bock, G., & Sokolowski, C. (1974) · Epilepsia · doi:10.1111/j.1528-1157.1974.tb04025.x · Cited by 47 · see citing works

In vivo comparison of putative probes of CYP3A4/5 activity: Erythromycin, dextromethorphan, and verapamil

KRECICSHEPARD, M., Barnas, C., SLIMKO, J., et al. (1999) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(99)70052-4 · Cited by 45 · see citing works

Sex-related differences in theophylline pharmacokinetics

Nafziger, A. N., & Bertino, J. (1989) · European Journal of Clinical Pharmacology · doi:10.1007/bf00609434 · Cited by 44 · see citing works

LIVER BLOOD FLOW DURING HIGH FREQUENCY OSCILLATION AND CONVENTIONAL MECHANICAL VENTILATION

Mackenzie, C. F., Roberts, H. G., Takeda, J., et al. (1984) · Anesthesiology · doi:10.1097/00000542-198409001-00027 · Cited by 44 · see citing works

The effect of hormone replacement therapy on CYP3A activity

Górski, J. (2000) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2000.110560 · Cited by 44 · see citing works

Evidence for the effect of gender on activity of (S)-mephenytoin 4???-hydroxylase (CYP2C19) in a Chinese population

Xu, Z., Huang, S., Xiao, Z., et al. (1997) · Pharmacogenetics · doi:10.1097/00008571-199704000-00004 · Cited by 41 · see citing works

The Effects of Age and Gender on the Optimal Premedication Dose of Intramuscular Midazolam

Nishiyama, T., Matsukawa, T., & Hanaoka, K. (1998) · Anesthesia & Analgesia · doi:10.1097/00000539-199805000-00038 · Cited by 41 · see citing works

Circulating maternal serum progesterone in high-risk pregnancies

Dawood, M. Y. (1976) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(76)90859-0 · Cited by 40 · see citing works

Piroxicam and naproxen plasma concentrations in patients with osteoarthritis: Relation to age, sex, efficacy and adverse events

Rugstad, H. E., Hundal, Ø., Holme, I., et al. (1986) · Clinical Rheumatology · doi:10.1007/bf02054259 · Cited by 40 · see citing works

Delayed gastric emptying in conscious male rats following chronic estrogen and progesterone treatment

Coşkun, J., Sevinç, A., Tevetoğlu, I. Ö., Alican, İ., Kurtel, H., & Yeğen, B. Ç. (1995) · Research in Experimental Medicine · doi:10.1007/bf02576773 · Cited by 40 · see citing works

Hormonal Effects on Drug Metabolism Through the CYP System: Perspectives on Their Potential Significance in the Era of Pharmacogenomics

Sarlis, N. J., & Gourgiotis, L. (2005) · Current Drug Targets - Immune Endocrine & Metabolic Disorders · doi:10.2174/156800805774912971 · Cited by 39 · see citing works

The Effects of Age and Gender on the Optimal Premedication Dose of Intramuscular Midazolam

Nishiyama, T., Matsukawa, T., & Hanaoka, K. (1998) · Anesthesia & Analgesia · doi:10.1213/00000539-199805000-00038 · Cited by 37 · see citing works

Cytochrome P450 3A4 activity in premenopausal and postmenopausal women, based on 6-beta-hydroxycortisol:cortisol ratios.

Burstein, A. H., Reiss, W. G., Kantor, E., et al. (1999) · PubMed · Cited by 32 · see citing works

Gender differences in hepatic induction and inhibition of theophylline pharmacokinetics and metabolism.

Jennings, T. S., Nafziger, A. N., Davidson, L. K., & Bertino, J. (1993) · PubMed · Cited by 28 · see citing works

Age- and gender-related differences in carbohydrate concentrations of α 1 -acid glycoprotein variants and the effects of glycoforms on their drug-binding capacities

Kishino, S., Nomura, A., Itoh, S., et al. (2002) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-002-0530-x · Cited by 27 · see citing works

Disposition of alprazolam in human volunteers. Differences between genders.

Kristjánsson, F., & Thorsteinsson, S. B. (1991) · PubMed · Cited by 27 · see citing works

Cytochrome P450 3A4 Activity in Premenopausal and Postmenopausal Women, Based on 6‐β‐Hydroxycortisol:Cortisol Ratios

Burstein, A. H., Reiss, W. G., Kantor, E. D., et al. (1998) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1998.tb03147.x · Cited by 25 · see citing works

The N-demethylation of imipramine correlates with the oxidation of S-mephenytoin (S/R-ratio). A population study.

Skjelbo, E., Gram, L. F., & Brøsen, K. (1993) · PubMed · Cited by 24 · see citing works

Hormonal Effects on Tirilazad Clearance in Women: Assessment of the Role of CYP3A

Fleishaker, J. C., Pearson, L. K., Pearson, P. G., et al. (1999) · The Journal of Clinical Pharmacology · doi:10.1177/009127009903900309 · Cited by 24 · see citing works

Sex, Age and Alfentanil Pharmacokinetics

&NA; (1991) · Clinical Pharmacokinetics · doi:10.2165/00003088-199121010-00006 · Cited by 20 · see citing works

Variability in the Bioavailability of Phenytoin Capsules in Males and Females

Meyer, M. C., Straughn, A. B., Mhatre, R. M., Shah, V. P., Chen, M., Williams, R. L., & Lesko, L. J. (2001) · Pharmaceutical Research · doi:10.1023/a:1011075502215 · Cited by 19 · see citing works

Pharmacokinetics and Pharmacodynamics of Adinazolam and N-Desmethyladinazolam after Oral and Intravenous Dosing in Healthy Young and Elderly Volunteers

Fleishaker, J. C., Hulst, L. K., S, S. A. E., et al. (1992) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199212000-00006 · Cited by 12 · see citing works

S‐mephenytoin, sparteine and debrisoquine oxidation: genetic polymorphisms in a Turkish population.

Basci, N., Brøsen, K., Bozkurt, A., et al. (1994) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1994.tb04383.x · Cited by 12 · see citing works

Phenotype distribution and gender-related differences of CYP2E1 activity in a Chinese population

Chen, X., Han, X., Jiang, C.-H., et al. (2002) · Xenobiotica · doi:10.1080/00498250210163270 · Cited by 10 · see citing works

Predictors of Heightened Platelet Reactivity Despite Dual-Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention

Price, M. J., Nayak, K. R., Barker, C. M., Kandzari, D. E., & Teirstein, P. S. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.01.341 · Cited by 145 · see citing works

Sex Differences in the Expression of Drug-Metabolizing and Transporter Genes in Human Liver

Yang, L., & Li, Y. (2012) · Journal of Drug Metabolism & Toxicology · doi:10.4172/2157-7609.1000119 · Cited by 135 · see citing works

Effect of Caffeine Consumption on the Risk for Neurological and Psychiatric Disorders: Sex Differences in Human

Jee, H. J., Lee, S. G., Bormate, K. J., & Jung, Y.-S. (2020) · Nutrients · doi:10.3390/nu12103080 · Cited by 111 · see citing works

Bile Acid Receptors and the Gut–Liver Axis in Nonalcoholic Fatty Liver Disease

Xue, R., Su, L., Lai, S., Wang, Y., Zhao, D., Fan, J., Chen, W., Hylemon, P. B., & Zhou, H. (2021) · Cells · doi:10.3390/cells10112806 · Cited by 95 · see citing works

Adverse Drug Reactions in Women's Health Care

Tharpe, N. (2011) · Journal of Midwifery & Women's Health · doi:10.1111/j.1542-2011.2010.00050.x · Cited by 64 · see citing works

Biological sex differences in pharmacokinetics and adverse drug reactions

Aljohmani, A., & Yildiz, D. (2026) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s00210-025-04721-8 · Cited by 35 · see citing works

Assessing City-Wide Pharmaceutical Emissions to Wastewater via Modelling and Passive Sampling

Zillien, C., Groenveld, T., Schut, O., Beeltje, H., Blanco-Ania, D., Posthuma, L., Roex, E., & Ragas, A. (2024) · Environment International · doi:10.1016/j.envint.2024.108524 · Cited by 13 · see citing works

Sex‐Dependent Effects of <scp>CYP2D6</scp> on the Pharmacokinetics of Berberine in Humans

Blöcher, J. A., Meyer‐Tönnies, M. J., Morof, F., Rönnpagel, V., Bethmann, J., Vollmer, M., Engeli, S., & Tzvetkov, M. V. (2025) · Clinical Pharmacology &amp; Therapeutics · doi:10.1002/cpt.3454 · Cited by 16 · see citing works

Study on the effects of Zhuanggu Guanjie Pill, a modern Chinese medicine formula, on the activities and mRNA expression of seven CYP isozymes in rats

Chai, Y., Xu, Y., Xia, Z., et al. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114521 · Cited by 8 · see citing works

Inhibition of cytochrome P450 enzymes by rhein in rat liver microsomes

Tang, J., Yang, H. S., Song, X., et al. (2008) · Phytotherapy Research · doi:10.1002/ptr.2572 · Cited by 55 · see citing works

Simultaneous evaluation of the activity of five cytochrome P450 enzymes by a cocktail study in healthy volunteers

Uchida, S. (2015) · Europe PMC (PubMed Central)

In vitro evaluation of the effects of traditional herbal formulas on human Cytochrome P450 isozymes

Jin, S. E., Ha, H., & Shin, H. (2013) · The FASEB Journal · doi:10.1096/fasebj.27.1_supplement.lb630

Effect of eurycomanone on cytochrome P450 isoforms CYP1A2, CYP2A6, CYP2C8, CYP2C9, CYP2C19, CYP2E1 and CYP3A4 in vitro

Pan, Y., Tiong, K. H., Abd-Rashid, B. A., Ismail, Z., Ismail, R., Mak, J. W., & Ong, C. E. (2013) · Journal of Natural Medicines · doi:10.1007/s11418-013-0794-8 · Cited by 16 · see citing works